Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 2,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pregnancy Clear all

Conditions: Diphtheria, Pertussis, Tetanus
Interventions: Placebo, Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed; Drug · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Up to 45 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 4
States / cities: Durham, North Carolina • Houston, Texas • Seattle, Washington

Conditions: Premature Birth, Birth Weight, Post Partum Depression, Health Care Utilization, Nutrition Deficiency Due to Insufficient Food, Housing Problems, Fetal Complications, Food Deprivation
Interventions: FreshRx Nourishing Healthy Starts; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 14 Years to 55 Years · Female only
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pregnancy
Interventions: Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019), Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 4,633 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 9
States / cities: Ann Arbor, Michigan • Detroit, Michigan • Ferndale, Michigan + 6 more

Conditions: Cervical Cancer, Precancerous Condition
Interventions: survey administration; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 24 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 8
States / cities: Cleveland, Ohio

Conditions: Human Immunodeficiency Viruses
Interventions: ARCHITECT HIV Ag/Ab Combo; Device
Lead sponsor: Abbott Diagnostics Division; Industry
Eligibility: Not listed
Enrollment: 635 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 13
States / cities: Phoenix, Arizona • St. Petersburg, Florida • Springfield, Illinois + 8 more

Conditions: Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary; Hypertension
Interventions: Fetal Tracheal Occlusion; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pregnancy
Interventions: Dietary and Lifestyle Counseling; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Migraine
Interventions: Rimegepant, Various, No intervention; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 16 Years to 49 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy, Migraine, Headache, Postpartum, Depression, Anxiety
Interventions: external Trigeminal Nerve Stimulation; Device
Lead sponsor: Cefaly Technology; Industry
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Darien, Connecticut

Conditions: Cardiac Output
Interventions: supine position, 15 degrees lateral tilt, 30 degrees lateral tilt; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2
Interventions: Insulin glargine, insulin NPH; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Congenital Heart Disease
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Analgesia, Obstetrical, Coagulation Defect; Postpartum, Nonsteroidals (NSAIDs)Toxicity, Postpartum Hemorrhage, Postoperative Pain, Ketorolac Adverse Reaction, Blood Loss, Postoperative
Interventions: Ketorolac Tromethamine 30 MG/ML, Placebos; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Perinatal Anxiety
Interventions: Coping with Anxiety through Living Mindfully (CALM) Pregnancy; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 157 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Gestational Diabetes
Interventions: Soy Group (Soy Protein + Isoflavones), Control Group (Minimize Soy Intake); Dietary Supplement
Lead sponsor: University of Massachusetts, Boston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infections, Meningococcal
Interventions: 4CMenB; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Pregnancy Related
Interventions: Water Birth; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Infertility
Interventions: AS900672-Enriched 50 microgram (mcg), AS900672-Enriched 100 mcg, AS900672-Enriched 150 mcg, Follitropin alfa 150 international unit (IU), Recombinant human chorionic gonadotropin (r-hCG); Drug
Lead sponsor: Merck KGaA, Darmstadt, Germany; Industry
Eligibility: 18 Years to 36 Years · Female only
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Rockland, Massachusetts

Conditions: Cystic Fibrosis, Contraception, Physician-Patient Relations, Pregnancy Complications
Interventions: MyVoice:CF; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pregnancy
Interventions: Clearblue Pregnancy Test; Diagnostic Test
Lead sponsor: SPD Development Company Limited; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Cypress, California

Conditions: Pregnancy Complications, Maternal Care Patterns, Patient Engagement
Interventions: Melanated Group Midwifery Care; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 15 Years to 49 Years · Female only
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Spina Bifida, Myelomeningocele, Myeloschisis
Interventions: NEOX Cord 1K; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Inflammatory Bowel Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2028
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Infection, Pregnancy
Interventions: Placebo, Probiotic dietary supplement; Drug · Dietary Supplement
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 3
States / cities: Aptos, California • Santa Cruz, California • Stanford, California

Search by objective public record fields.

Pertussis Vaccine in Healthy Pregnant Women

Fresh RX: NHS 2020

Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1

Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study

Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

Assessing Effects of Lateral Tilt on Cardiac Output Using a Non-invasive Technique

RCT Glargine vs NPH for Treatment of DM in Pregnancy

A Study of Pregnancy Outcomes in Congenital Heart Disease

IV Ketorolac on Platelet Function Post-Cesarean Delivery

Pregnancy and Anxious Thoughts: The Role of the Immune and Endocrine Systems

Soy Supplementation and Gestational Diabetes

Safety of 4CMenB Exposure During Pregnancy

Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

MyVoice:CF Decision Aid for Women With Cystic Fibrosis

Clearblue Pregnancy Test Lay User Usage Study

Melanated Group Midwifery Care (MGMC)

Fetoscopic NEOX Cord 1K® Spina Bifida Repair

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy